We at the American Diabetes Association (ADA) believe that the best days of everyone living with diabetes lay ahead. As diabetes experts, researchers, academics and health care professionals, you know how important it is that we give those living with diabetes tools so they can feel empowered to manage their disease each and every day. Whether you’re a member of their diabetes care team or a researcher searching for the next life-changing treatment or cure, we’re here to help you show up for them—so they can do what it takes to live their best lives.
Patients living with type 2 diabetes are at a higher risk for heart disease and stroke—in fact, people living with diabetes are two times more likely to develop and die from cardiovascular disease.
That’s why the American Diabetes Association joined forces with our friends at the American Heart Association to launch Know Diabetes by Heart™. This groundbreaking collaborative initiative aims to reduce cardiovascular deaths, heart attacks and strokes in people living with type 2 diabetes by raising awareness and understanding of the risks and supporting health care providers in educating their patients living with type 2 diabetes.
Cardiovascular disease is the leading cause of death and a major cause of heart attacks, strokes and heart failure for people living with type 2 diabetes—yet only half recognize their risk or have discussed their risk for heart attacks or strokes with their health care providers. That’s where you come in.
Check out our resources for professionals. From the latest cardiovascular and diabetes science, patient educational and clinical care tools and quality improvement programs, you’ll find everything you need so we can win this fight. Together.
Here’s a sobering fact to consider: In the last 20 years, despite more technology, more education and more drug therapies, the average A1C for a person with diabetes has not changed. The number of patients with an A1C over 9% has actually increased. We must do more to change the trend so those living with diabetes can not just manage but thrive. That’s why the ADA is embarking on a new campaign: Overcoming Therapeutic Inertia: Accelerating Diabetes Care for Life. Its purpose? To address all the forces and factors that contribute to delays in implementing the most effective care for each person living with diabetes.
Working in collaboration with national vision benefits provider VSP® Vision Care and Regeneron Pharmaceuticals, Inc., the ADA is excited to launch Focus on Diabetes™, a brand-new eye health initiative focused on the crucial role annual comprehensive eye exams play in the early detection, intervention and prevention of eye disease and vision loss caused by diabetes. The reality is, diabetes is the leading cause of new cases of blindness among adults—which is why we have embarked on this initiative to raise awareness and provide resources for those who may be at risk for a diabetes-related eye disease, provide patient support and education to those affected by it and educate health care professionals about diabetes-related eye disease and how to prevent it.
The ADA’s Precision Medicine in Diabetes Initiative aims to improve diabetes care by realizing the promise of precision medicine for diabetes. Engaging a broad group of stakeholder representatives, we are compiling a Taskforce that will, over the coming 5 years, formulate a consensus statement on precision diabetes medicine. By applying the appropriate treatment for the appropriate person at the appropriate time, we will realize our vision of longer, healthier lives for people with diabetes.
ADA’s Time in Range (TIR) Initiative has an ambitious goal: to enable people with diabetes to make informed choices to measure and monitor blood glucose and to drive awareness and adoption of new standards, technologies and guidelines to better measure and manage diabetes. For people using continuous glucose monitoring (CGM), TIR provides a new dimension to diabetes management beyond A1C to provide guidance on keeping blood glucose levels as close to a normal range as possible. Based on evidence-based guidelines, TIR will provide both providers and patients information on tools to improve diabetes control while minimizing dangerous extremes in blood glucose levels.